Thanks again Tuca. Nice to see those numbers but wish someone could authoritatively explain what we are seeing with the Generic V scripts bouncing up and down.
Might be that supply is constrained but I am still concerning about even the simple fact that a generic being available is messing up the insurance reimbursement formulary tiers, thus slowing our growth.
Oh well, let's enjoy what we have right now as the market should take this as Amarin not losing the entire U.S. market and by right should return our stock price to the lower teens.
Scripts for week ending 08/01/2021 Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.